QIAGEN N.V. to release results for Q1 2024 and hold webcast

Written by Customer Service on . Posted in Public Companies.

Venlo, The Netherlands, April 09, 2024 (GLOBE NEWSWIRE) — QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the first quarter 2024.

Press release date / time: Monday, April 29, shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 New York time.

Conference call date / time: Tuesday, April 30, at 15:00 Frankfurt time / 14:00 London time / 09:00 New York time. 

Three options for joining the conference call

Register for call back connection – Click here: Connect me
Service is available 15 minutes before the call starts 

Dial-in by phone
U.S.: +1 646 828 8193
UK: +44 (0)330 165 3655
GER: +49 (0)69 6610 2492
Conference ID: 2903795
To avoid waiting time, please join the event conference 5-10 minutes prior to the start time. 

Access the audio webcast – Click here: Access Webcast

 A conference call replay will be available by using the following link:
https://event.webcasts.com/starthere.jsp?ei=1643475&tp_key=6453d016b6  

Contact: IR@qiagen.com 

About QIAGEN
QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics).
As of December 31, 2023, QIAGEN employed approximately 6,000 people in over 35 locations worldwide. 

Further information can be found at http://www.qiagen.com. 

source: QIAGEN N.V. 
category: Financial  

 

CONTACT: John Gilardi
QIAGEN N.V.
+49 2103 29 11711
ir@qiagen.com

Domenica Martorana
QIAGEN N.V.
+49 2103 29 11244
ir@qiagen.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.